WallStSmart
JSPR

Jasper Therapeutics Inc

NASDAQ: JSPR · HEALTHCARE · BIOTECHNOLOGY

$0.94
+5.13% today

Updated 2026-04-30

Market cap
$26.03M
P/E ratio
P/S ratio
EPS (TTM)
$-3.95
Dividend yield
52W range
$1 – $7
Volume
0.4M

Jasper Therapeutics Inc (JSPR) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+22.6%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+66.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.9%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-4.5%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-12-31$-0.54+33.8%$1.79$1.84+2.8%
2025-11-10$-1.13+43.5%$1.78$1.70-4.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.82$-0.54+33.8%
2025-09-30$-2.00$-1.13+43.5%
2025-06-30$-1.90$-1.74+8.4%
2025-03-31$-1.48$-1.41+4.5%
2024-12-31$-1.23$-1.62-31.9%$1.17M-42.8%
2024-09-30$-1.07$-1.24-15.9%
2024-06-30$-1.09$-0.97+11.0%
2024-03-31$-1.23$-1.03+16.3%
2023-12-31$-1.61$-1.50+6.8%$2.05M
2023-09-30$-0.16$-0.16+0.0%
2023-06-30$-0.15$-0.15+0.0%$1.75M
2023-03-31$-0.16$-0.16+0.0%$-313000.00

Frequently asked questions

Has Jasper Therapeutics Inc beaten earnings estimates?
Jasper Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +22.6% over the last 4 quarters.
How does JSPR stock react to earnings?
JSPR stock has moved an average of -0.9% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.